Added to YB: 2026-08-12
Pitch date: 2026-08-09
NVO [neutral]
Novo Nordisk A/S
-17.08%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.1T
Pitch Price
DKK 46.58
Price Target
N/A
Dividend
4.52%
EV/EBITDA
7.07
P/E
9.88
EV/Sales
3.76
Sector
Pharmaceuticals
Category
growth
Show full summary:
MM Top Ideas List: 20 Stocks Worth Watching - Novo Nordisk A/S
NVO (watchlist): Danish pharma leader in diabetes/obesity care (Ozempic, Wegovy, Rybelsus). Oral Wegovy pill—first oral GLP-1 for weight loss—could be major growth driver, expanding market vs cannibalizing. Strong launch: 5M+ US scripts in 30wks, ~1.5M users globally. Trades 13x 2028 net income.
Read full article (1 min)